<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>300</height>
  <width>600</width>
  <title>🩸 Reengineering Coagulation: Bridging Factors, Bypassing Factor VIII, Transforming Hemophilia</title>
  <description>🩸 Can you replace factor VIII without actually replacing factor VIII? Emicizumab does something more ingenious: this bispecific antibody bridges factor IXa and factor X, functionally recreating a critical role of factor VIIIa. 🔬 After screening ~40,000 candidates, researchers engineered a therapy that enables convenient subcutaneous prophylaxis and works with or without factor VIII inhibitors. 💉 🏆 Recognized with the 2026 Lasker–DeBakey Clinical Medical Research Award, it offers a powerful lesson: sometimes the best way to replace a missing protein is to reengineer its function. 🧬 </description>
  <author_name>Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!</author_name>
  <author_url>http://www.MasterMedFacts.com</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/42898245/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="300" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/206277500</thumbnail_url>
</oembed>
